
Zosano Pharma Corporation ZSAN
Zosano Pharma Corporation DSO Ratio | ZSAN
Annual DSO Ratio Zosano Pharma Corporation
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 33.9 | - | - | - | - | - | 64.7 | 7.08 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 64.7 | 7.08 | 35.2 |
Quarterly DSO Ratio Zosano Pharma Corporation
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 81.9 | - | 33.3 | 65.5 | 15.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 79.7 | 53 | - | 27.1 | 20 | 3.16 | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 81.9 | 3.16 | 42.1 |
DSO Ratio of other stocks in the Biotechnology industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Фармсинтез
LIFE
|
209 | - | - | - | ||
|
Ayala Pharmaceuticals
AYLA
|
61.7 | - | - | $ 7.46 M | ||
|
Rhythm Pharmaceuticals
RYTM
|
42.9 | $ 101.8 | 0.08 % | $ 6.62 B | ||
|
Seer
SEER
|
47.3 | $ 1.95 | 0.26 % | $ 108 M | ||
|
Precigen
PGEN
|
91.2 | $ 6.87 | 0.14 % | $ 2.15 B | ||
|
SIGA Technologies
SIGA
|
47.1 | $ 3.2 | 1.86 % | $ 229 M | ||
|
Syndax Pharmaceuticals
SNDX
|
48.3 | $ 19.94 | 0.05 % | $ 1.73 B | ||
|
Soligenix
SNGX
|
87.4 | $ 0.38 | 1.18 % | $ 1.97 M | ||
|
Sarepta Therapeutics
SRPT
|
412 | $ 20.94 | 0.04 % | $ 2.1 B | ||
|
Stoke Therapeutics
STOK
|
7.52 | $ 30.05 | 0.81 % | $ 1.78 B | ||
|
Sutro Biopharma
STRO
|
22.4 | $ 19.1 | 0.34 % | $ 162 M | ||
|
Supernus Pharmaceuticals
SUPN
|
83.7 | $ 42.43 | 0.23 % | $ 2.4 B | ||
|
Savara
SVRA
|
2.41 K | $ 5.53 | 2.98 % | $ 1.23 B | ||
|
China SXT Pharmaceuticals
SXTC
|
358 | $ 2.24 | 0.45 % | $ 1.52 M | ||
|
Takeda Pharmaceutical Company Limited
TAK
|
79.3 | $ 18.32 | 1.49 % | $ 28.9 B | ||
|
Bio-Techne Corporation
TECH
|
63.6 | $ 72.31 | 0.01 % | $ 11.3 B | ||
|
Tenax Therapeutics
TENX
|
566 | $ 1.98 | 2.06 % | $ 77.7 M | ||
|
Teva Pharmaceutical Industries Limited
TEVA
|
823 | $ 36.76 | 1.21 % | $ 42.1 B | ||
|
TG Therapeutics
TGTX
|
129 | $ 55.74 | 0.58 % | $ 8.04 B | ||
|
Sol-Gel Technologies Ltd.
SLGL
|
52.4 | $ 69.37 | 0.35 % | $ 193 M | ||
|
UroGen Pharma Ltd.
URGN
|
88.7 | $ 43.82 | 0.02 % | $ 2.11 B | ||
|
United Therapeutics Corporation
UTHR
|
36.1 | $ 497.97 | 2.12 % | $ 22.1 B | ||
|
Spero Therapeutics
SPRO
|
242 | $ 1.19 | 0.41 % | $ 66.7 M | ||
|
Scholar Rock Holding Corporation
SRRK
|
445 | $ 57.42 | 3.78 % | $ 6.59 B | ||
|
Jounce Therapeutics
JNCE
|
2.32 | - | - | $ 98.4 M | ||
|
Verrica Pharmaceuticals
VRCA
|
27.2 | $ 5.26 | 0.75 % | $ 56 M | ||
|
Vertex Pharmaceuticals Incorporated
VRTX
|
55.7 | $ 528.9 | 0.22 % | $ 135 B | ||
|
Verastem
VSTM
|
52 | $ 8.08 | 0.55 % | $ 560 M | ||
|
vTv Therapeutics
VTVT
|
29.4 | $ 32.79 | 0.03 % | $ 130 M | ||
|
Voyager Therapeutics
VYGR
|
14.8 | $ 3.4 | 3.85 % | $ 200 M | ||
|
Aravive
ARAV
|
16.8 | - | -13.39 % | $ 1.45 M | ||
|
Wave Life Sciences Ltd.
WVE
|
11.5 | $ 4.91 | 1.03 % | $ 828 M | ||
|
Tonix Pharmaceuticals Holding Corp.
TNXP
|
139 | $ 13.16 | 0.15 % | $ 112 M | ||
|
Xenetic Biosciences
XBIO
|
365 | $ 4.28 | 0.86 % | $ 7.28 M | ||
|
XBiotech
XBIT
|
40.8 | $ 2.18 | 0.23 % | $ 66.5 M | ||
|
Exicure
XCUR
|
-4.16 | $ 1.41 | 12.8 % | $ 8.88 M | ||
|
Xenon Pharmaceuticals
XENE
|
35.7 | $ 59.55 | 0.18 % | $ 4.72 B | ||
|
Xeris Pharmaceuticals
XERS
|
57.2 | $ 8.48 | 0.12 % | $ 1.36 B |